The increased cell and gene therapy workload forced CBER staff to limit sponsor interactions and convert live meetings to "written responses only" status. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
